Huetteman, A., Ali, N. A., Sallman, D., Padron, E., Kuykendall, A., Chan, O., Xie, Z., Walker, A., Yun, S., Reynolds, S., Sweet, K., Komrokji, R., Lancet, J. (2025). Outcomes of hypomethylating agent (HMA)-based therapy in patients with myelodysplastic syndrome with fibrosis. Blood. https://doi.org/10.1182/blood-2025-3853